Status:
COMPLETED
PREPARE - Primary Prevention Parameters Evaluation
Lead Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Collaborating Sponsors:
Medtronic
Conditions:
Tachycardia, Ventricular
Implantable Cardioverter Defibrillator (ICD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implant...
Eligibility Criteria
Inclusion
- Patient is a candidate for a non-replacement Medtronic ICD device from the Marquis family or has had a non-replacement Medtronic Marquis based ICD system implanted within the previous 6 months and has not had any appropriately treated spontaneous VT/VF episodes during that time.
Exclusion
- Patient has history of spontaneous sustained symptomatic ventricular arrhythmias.
- If patient has had an electrophysiology test in the past, and has sustained inducible VT \<180 bpm.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00279279
Start Date
October 1 2003
End Date
May 1 2006
Last Update
October 26 2006
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Mesa, Arizona, United States
3
Phoenix, Arizona, United States
4
San Diego, California, United States